Robert Andrew Berman, Chief Executive Officer at Hancock Jaffe Laboratories, Inc. (HJLI), bought 18,382 shares at $1.36 ($25K) on 2019-03-12, disclosed to the SEC on 2019-04-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| NVNO | BUY | 2021-11-19 | $15K | — | Filing → |
| NVNO | BUY | 2021-11-18 | $16K | — | Filing → |
| HJLI | BUY | 2021-05-19 | $16K | — | Filing → |